Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [18F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2021, Jahrgang: 48, Heft: 6, Pages: 1932-1943 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-020-05137-7 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-020-05137-7 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00259-020-05137-7 
|
| Verfasserangaben: | Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1877938254 | ||
| 003 | DE-627 | ||
| 005 | 20240307091747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240111s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-020-05137-7 |2 doi | |
| 035 | |a (DE-627)1877938254 | ||
| 035 | |a (DE-599)KXP1877938254 | ||
| 035 | |a (OCoLC)1425217344 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sachpekidis, Christos |d 1983- |e VerfasserIn |0 (DE-588)1099707269 |0 (DE-627)858738651 |0 (DE-576)469338482 |4 aut | |
| 245 | 1 | 0 | |a Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma |c Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss |
| 246 | 3 | 3 | |a Interim (18 F) FDG PET/CT can predict response to anti-PD-one treatment in metastatic melanoma |
| 264 | 1 | |c 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 18 December 2020 | ||
| 500 | |a Im Titel steht der Ausdruck (18 F) in eckiger Klammer, "18" ist dabei hochgestellt | ||
| 500 | |a Gesehen am 11.01.2024 | ||
| 520 | |a In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [18F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. | ||
| 650 | 4 | |a Anti-PD-1 therapy | |
| 650 | 4 | |a EORTC criteria | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Metastatic melanoma | |
| 650 | 4 | |a PERCIMT criteria | |
| 650 | 4 | |a Treatment response evaluation | |
| 700 | 1 | |a Kopp-Schneider, Annette |e VerfasserIn |0 (DE-588)1119160545 |0 (DE-627)872460444 |0 (DE-576)178153206 |4 aut | |
| 700 | 1 | |a Pan, Leyun |e VerfasserIn |0 (DE-588)1119758858 |0 (DE-627)872860906 |0 (DE-576)479980624 |4 aut | |
| 700 | 1 | |a Papamichail, Dimitrios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 700 | 1 | |a Dimitrakopoulou-Strauss, Antonia |d 1963- |e VerfasserIn |0 (DE-588)1076688373 |0 (DE-627)835256901 |0 (DE-576)167486055 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 48(2021), 6, Seite 1932-1943 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma |
| 773 | 1 | 8 | |g volume:48 |g year:2021 |g number:6 |g pages:1932-1943 |g extent:12 |a Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00259-020-05137-7 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00259-020-05137-7 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240111 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1076688373 |a Dimitrakopoulou-Strauss, Antonia |m 1076688373:Dimitrakopoulou-Strauss, Antonia |d 50000 |e 50000PD1076688373 |k 0/50000/ |p 7 |y j | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 6 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 1119758858 |a Pan, Leyun |m 1119758858:Pan, Leyun |d 50000 |e 50000PP1119758858 |k 0/50000/ |p 3 | ||
| 998 | |g 1119160545 |a Kopp-Schneider, Annette |m 1119160545:Kopp-Schneider, Annette |d 50000 |e 50000PK1119160545 |k 0/50000/ |p 2 | ||
| 998 | |g 1099707269 |a Sachpekidis, Christos |m 1099707269:Sachpekidis, Christos |d 50000 |e 50000PS1099707269 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1877938254 |e 4454565678 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"pubHistory":["29.2002 -"],"title":[{"subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title_sort":"European journal of nuclear medicine and molecular imaging","title":"European journal of nuclear medicine and molecular imaging"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2002-","publisher":"Springer-Verl.","publisherPlace":"Heidelberg [u.a.]","dateIssuedKey":"2002"}],"part":{"text":"48(2021), 6, Seite 1932-1943","year":"2021","issue":"6","extent":"12","volume":"48","pages":"1932-1943"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaEuropean journal of nuclear medicine and molecular imaging","language":["eng"],"id":{"zdb":["2098375-X"],"issn":["1619-7089"],"eki":["359787258"]},"recId":"359787258"}],"name":{"displayForm":["Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss"]},"id":{"doi":["10.1007/s00259-020-05137-7"],"eki":["1877938254"]},"recId":"1877938254","language":["eng"],"titleAlt":[{"title":"Interim (18 F) FDG PET/CT can predict response to anti-PD-one treatment in metastatic melanoma"}],"physDesc":[{"extent":"12 S."}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma","title_sort":"Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma"}],"person":[{"role":"aut","family":"Sachpekidis","given":"Christos","display":"Sachpekidis, Christos"},{"display":"Kopp-Schneider, Annette","family":"Kopp-Schneider","given":"Annette","role":"aut"},{"display":"Pan, Leyun","given":"Leyun","family":"Pan","role":"aut"},{"role":"aut","display":"Papamichail, Dimitrios","family":"Papamichail","given":"Dimitrios"},{"role":"aut","family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe"},{"given":"Jessica C.","family":"Hassel","display":"Hassel, Jessica C.","role":"aut"},{"role":"aut","family":"Dimitrakopoulou-Strauss","given":"Antonia","display":"Dimitrakopoulou-Strauss, Antonia"}],"note":["Published online: 18 December 2020","Im Titel steht der Ausdruck (18 F) in eckiger Klammer, \"18\" ist dabei hochgestellt","Gesehen am 11.01.2024"]} | ||
| SRT | |a SACHPEKIDIINTERIM18F2021 | ||